These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 15154706)
1. Optimization of the uptake method for estimating renal clearance of 99mTc mercaptoacetyltriglycine. Zhao C; Shuke N; Okizaki A; Yamamoto W; Usui K; Kikuchi K; Kaneko S; Yachiku S; Sasajima T; Aburano T Nucl Med Commun; 2004 Feb; 25(2):159-66. PubMed ID: 15154706 [TBL] [Abstract][Full Text] [Related]
2. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance in patients with impaired renal function. Erdil TY; Dede F; Tuglular S; Sen F; Ones T; Farsakoglu Z; Inanir S; Ozener C; Akoglu E; Turoglu T Nucl Med Commun; 2006 Feb; 27(2):191-6. PubMed ID: 16404234 [TBL] [Abstract][Full Text] [Related]
3. Tc-99m mercaptoacetyltriglycine clearance: comparison of camera-assisted methods. Bocher M; Shrem Y; Tappiser A; Klein M; Schechter D; Taylor A; Chisin R Clin Nucl Med; 2001 Sep; 26(9):745-50. PubMed ID: 11507290 [TBL] [Abstract][Full Text] [Related]
4. [Proposal on new formulas for renal depth in the technetium-99m-mercaptoacetyltriglycine (MAG3) scintigraphy]. Uchiyama K; Kuniyasu Y; Niio Y; Hasebe S; Yamada M; Shinohara H; Matsuoka S; Shima H; Obuchi M; Takizawa K; Honda M; Kawabe R; Kuwayama J; Iwasaki S; Ideura T Kaku Igaku; 1997 Mar; 34(3):159-66. PubMed ID: 9136524 [TBL] [Abstract][Full Text] [Related]
5. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine. Sohaib M; Rafique A; Saeed S; Afshan A Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of renal function with 99mTc-MAG3 using semiautomated regions of interest. Inoue Y; Yoshikawa K; Yoshioka N; Watanabe T; Saegusa S; Kaneko Y; Yokoyama I; Ohtomo K J Nucl Med; 2000 Dec; 41(12):1947-54. PubMed ID: 11138677 [TBL] [Abstract][Full Text] [Related]
7. Reassessment of the reproducibility of Technetium-99m mercaptoacetyltriglycine clearance. De Sadeleer C Nucl Med Rev Cent East Eur; 2005; 8(1):15-20. PubMed ID: 15977142 [TBL] [Abstract][Full Text] [Related]
8. Determination of extrarenal plasma clearance and hepatic uptake of technetium-99m-mercaptoacetyltriglycine in cats. Drost WT; McLoughlin MA; Mattoon JS; Lerche P; Samii VF; DiBartola SP; Chew DJ; Barthez PY Am J Vet Res; 2003 Sep; 64(9):1076-80. PubMed ID: 13677382 [TBL] [Abstract][Full Text] [Related]
9. Determination of the technetium-99m mercaptoacetyltriglycine plasma clearance in children by means of a single blood sample: a multicentre study. The Paediatric Task Group of the EANM. Piepsz A; Gordon I; Hahn K; Kolinska J; Kotzerke J; Sixt R Eur J Nucl Med; 1993 Mar; 20(3):244-8. PubMed ID: 8462614 [TBL] [Abstract][Full Text] [Related]
10. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume. Esteves FP; Taylor A; Manatunga A; Folks RD; Krishnan M; Garcia EV AJR Am J Roentgenol; 2006 Dec; 187(6):W610-7. PubMed ID: 17114514 [TBL] [Abstract][Full Text] [Related]
11. Simplified algorithms for the estimation of 99Tcm-MAG3 clearance. De Sadeleer C; Piepsz A; Tondeur M; Ham HR Nucl Med Commun; 2000 Jan; 21(1):65-9. PubMed ID: 10717904 [TBL] [Abstract][Full Text] [Related]
13. Deadtime correction in measurement of fractional renal accumulation of 99Tcm-MAG3. Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Ohtomo K Nucl Med Commun; 1999 Mar; 20(3):267-72. PubMed ID: 10093077 [TBL] [Abstract][Full Text] [Related]
14. A simple objective parameter for perfusion study of renal transplant. Koizumi K; Kakiuchi H; Saguchi T; Inoue S; Fuse S; Kawakami E; Yamazaki A; Kozaki K; Nagao T Ann Nucl Med; 2001 Feb; 15(1):27-32. PubMed ID: 11355778 [TBL] [Abstract][Full Text] [Related]
15. Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate. Russell CD; Dubovsky EV J Nucl Med; 1999 Jul; 40(7):1122-4. PubMed ID: 10405130 [TBL] [Abstract][Full Text] [Related]
16. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance. Taylor A; Manatunga A; Morton K; Reese L; Prato FS; Greenberg E; Folks R; Kemp BJ; Jones ME; Corrigan PE; Galt J; Eshima L Radiology; 1997 Jul; 204(1):47-54. PubMed ID: 9205222 [TBL] [Abstract][Full Text] [Related]
17. Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample. Müller-Suur R; Magnusson G; Bois-Svensson I; Jansson B Eur J Nucl Med; 1991; 18(1):28-31. PubMed ID: 1826882 [TBL] [Abstract][Full Text] [Related]
18. Estimation of Tc-99m MAG3 clearance using camera-based methods without blood sampling. Inoue Y; Ohtomo K Clin Nucl Med; 2011 Nov; 36(11):1012-6. PubMed ID: 21975390 [TBL] [Abstract][Full Text] [Related]
19. Recovery of renal retention function by differentiating the Patlak-Rutland plot. Kuyvenhoven JD; Ham HR; Piepsz A Nucl Med Commun; 2004 May; 25(5):501-7. PubMed ID: 15100510 [TBL] [Abstract][Full Text] [Related]
20. Technetium-99m mercaptoacetyltriglycine clearance values in children with minimal renal disease: can a normal range be determined? Meyer G; Piepsz A; Kolinska J; Lepej J; Sixt R; Hahn K Eur J Nucl Med; 1998 Jul; 25(7):760-5. PubMed ID: 9662599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]